SLC26A8: A Potential Drug Target for Cancer and Neurodegenerative Diseases

Target Name: SLC26A8

NCBI ID: G116369

SLC26A8

SLC26A8: A Potential Drug Target for Cancer and Neurodegenerative Diseases

SLC26A8 is a member of the Sodium Chloride Transporter (SLC) family, which is a large family of transmembrane proteins that play a vital role in the regulation of ion transport across cell membranes. SLC26A8 is a splice variant protein, which means that it has different variants of the gene that result in differences in its amino acid sequence.

SLC26A8 is a 26kDa protein that is expressed in various tissues and organs, including the brain, heart, kidney, and liver. It is primarily localized to the endoplasmic reticulum (ER), which is the protein synthesis and quality control center of the cell. SLC26A8 is also known to be expressed in the placenta, where it is involved in the regulation of fetal ion transport.

SLC26A8 is a protein that is known to play a critical role in the regulation of a variety of cellular processes, including metabolism, growth, and survival. One of its well-known functions is its role in the regulation of sodium homeostasis, which is the maintain balance of sodium and water in the body.

SLC26A8 is involved in the regulation of the activity of several sodium channels, including the Na+/K+-ATPase, which is responsible for maintaining the resting membrane potential of the cell. SLC26A8 is known to interact with this channel and modulates its activity, which can have a significant impact on the cell's ability to generate electrical signals and maintain its integrity.

SLC26A8 is also involved in the regulation of several cellular processes that are critical for cell survival, including cell growth, apoptosis, and inflammation. For example, SLC26A8 has been shown to be involved in the regulation of cell cycle progression, and it has been shown to play a role in the regulation of cell apoptosis.

In addition to its role in cellular processes, SLC26A8 is also a potential drug target. The SLC26A8 gene has been shown to be a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of SLC26A8 as a drug target is its involvement in the regulation of cellular processes that are associated with several diseases, including cancer. SLC26A8 has been shown to be involved in the regulation of cell cycle progression, which is a critical process for the development and progression of cancer.

SLC26A8 has also been shown to be involved in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. This process is important for maintaining tissue homeostasis and for the regulation of immune responses. However, dysregulation of cell apoptosis has been implicated in the development and progression of several diseases, including cancer.

In addition to its involvement in cancer, SLC26A8 has also been shown to be involved in the regulation of neurodegenerative diseases. For example, SLC26A8 has been shown to be involved in the regulation of the aggregation of beta-amyloid peptides, which are a hallmark of neurodegenerative diseases such as Alzheimer's disease.

SLC26A8 is also involved in the regulation of autoimmune disorders, which are a group of diseases in which the immune system attacks the body's own tissues. SLC26A8 has been shown to be involved in the regulation of the production and activity of T cells, which are a key component of the immune system.

In conclusion, SLC26A8 is a splice variant protein that is involved in a variety of cellular processes that are critical for

Protein Name: Solute Carrier Family 26 Member 8

Functions: Acts as a DIDS-sensitive anion exchanger mediating chloride, sulfate and oxalate transport. May fulfill critical anion exchange functions in male germ line during meiosis and hence may play a role in spermatogenesis. May be involved in a new regulatory pathway linking sulfate transport to RhoGTPase signaling in male germ cells. A critical component of the sperm annulus that is essential for correct sperm tail differentiation and motility and hence male fertility. May form a molecular complex involved in the regulation of chloride and bicarbonate ions fluxes during sperm capacitation

The "SLC26A8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC26A8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets